Challenges and perspectives of CAR-T cell therapy in solid tumours: insights from gastric cancer Summary CAR-T cell therapy, while effective in hematological malignancies, faces significant challenges in solid tumors like gastric cancer. These hurdles include Read More
Tags :CART
Education, Research & Positions
Immune correlates of anti-BCMA CAR-T products idecabtagene vicleucel and ciltacabtagene
Immune correlates of anti-BCMA CAR-T products idecabtagene vicleucel and ciltacabtagene autoleucel in a real-world cohort of patients with multiple myeloma Summary Real-world data on idecabtagene vicleucel (ide-cel) and ciltacabtagene autoleucel (cilta-cel) CAR-T therapy for multiple Read More
Education, Research & Positions
CAR-T cell therapy for cancer: current challenges and future directions
CAR-T cell therapy for cancer: current challenges and future directions Summary CAR-T cell therapy has revolutionized cancer treatment, particularly for hematologic malignancies, by engineering a patient’s immune cells to target and destroy cancer cells. Read More